{"product_id":"2940153774541","title":"Dermatomyositis, A Simple Guide To The Condition, Diagnosis, Treatment And Related Conditions","description":"\u003cp\u003eDermatomyositis is a medical muscle disorder characterized by inflammation and a skin rash.\u003cbr\u003eIt is a form of inflammatory myopathy (muscle disease).\u003cbr\u003eDermatomyositis is connective tissue disease characterized by inflammation of muscles.\u003cbr\u003eAlthough dermatomyositis involves the skin and muscles, it may also involve other parts of the body such as joints, esophagus, lungs and heart.\u003cbr\u003eIt is possible to divide the dermatomyositis into three basic subgroups according to cause:\u003cbr\u003e1. Idiopathic dermatomyositis in adults.\u003cbr\u003e2. Childhood dermatomyositis or myositis with necrotizing vasculitis.\u003cbr\u003e3. Dermatomyositis linked with malignancy.\u003cbr\u003eIt may be due to a viral infection involving the muscles or a disorder with the body's immune system.\u003cbr\u003eIt can also sometimes occur in patients who have cancer of the lung, abdomen, or other body organ.\u003cbr\u003eAny person can develop dermatomyositis but it frequently happens in adults aged 40-60.\u003cbr\u003eDermatomyositis affects children aged 5-15 and as well as adults.\u003cbr\u003eThere is:\u003cbr\u003e1. Sudden muscle weakness, stiffness, or soreness\u003cbr\u003e2. Purple-red skin rash\u003cbr\u003e3. Purple or violet colored upper eyelids\u003cbr\u003eAutoantibodies are present:\u003cbr\u003ea. Antinuclear antibody (ANA) finding is positive in patients with dermatomyositis.\u003cbr\u003eb. Anti-Mi-2 antibodies are particular to dermatomyositis\u003cbr\u003eMuscle biopsy can be diagnostic.\u003cbr\u003eEarly starting of medical treatment is important.\u003cbr\u003eThe disease is treated with anti-inflammatory medicines called corticosteroids and drugs that suppress the immune system.\u003cbr\u003eIntravenous immunoglobulin is proper treatment in patients with resistant dermatomyositis or aggressive disease\u003cbr\u003eOther treatments are antimalarial agents and immunomodulatory therapies\u003cbr\u003e1 in 5 people may recover and the symptoms disappear completely.\u003cbr\u003eDoctors have reported several such cases, especially in children.\u003cbr\u003eMost cases are able to survive but may develop residual disability and muscle weakness.\u003c\/p\u003e\u003cp\u003eTABLE OF CONTENT\u003cbr\u003eIntroduction\u003cbr\u003eChapter 1 Dermatomyositis\u003cbr\u003eChapter 2 Causes\u003cbr\u003eChapter 3 Symptoms\u003cbr\u003eChapter 4 Diagnosis\u003cbr\u003eChapter 5 Treatment\u003cbr\u003eChapter 6 Prognosis\u003cbr\u003eChapter 7 Polymyositis\u003cbr\u003eChapter 8 Systemic Lupus Erythematosus\u003cbr\u003eEpilogue\u003c\/p\u003e","brand":"Kenneth Kee","offers":[{"title":"Default Title","offer_id":47111092797680,"sku":"2940153774541","price":2.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0737\/7593\/9824\/files\/2940153774541_p0.jpg?v=1764060294","url":"https:\/\/shop-qa.barnesandnoble.com\/products\/2940153774541","provider":"Barnes \u0026 Noble (DEV)","version":"1.0","type":"link"}